0.00Open0.00Pre Close0 Volume0 Open Interest7.50Strike Price0.00Turnover0.00%IV-216.46%PremiumDec 20, 2024Expiry Date5.13Intrinsic Value100Multiplier20DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.46Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Oramed Pharmaceuticals Stock Discussion
Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt
NEW YORK, Oct. 7, 2024 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) ("Oramed"), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, today announced the execution of definitive agreements for the restructuring of a portion of its existing Senior Secured Promissory Note from Scilex Holding Compa...
your turn tonight?
$Calyxt (CLXT.US)$ $Viveve Medical (VIVE.US)$ $Celyad Oncology (CYAD.US)$ $Bit Digital (BTBT.US)$ $Rivian Automotive (RIVN.US)$ $Oramed Pharmaceuticals (ORMP.US)$ $MGO Global (MGOL.US)$ $Tritium DCFC (DCFC.US)$ $Bed Bath & Beyond Inc (BBBY.US)$ $BIT Mining (BTCM.US)$
No comment yet